| 1 |
31180700 | BDNF association study with obsessive-compulsive disorder, its clinical characteristics, and response to fluvoxamine-treatment in Iranian patients. | 2020 Apr |
1 |
| 2 |
28410959 | The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia. | 2017 May |
2 |
| 3 |
25756551 | Improvement in verbal memory following SSRI augmentation of antipsychotic treatment is associated with changes in the expression of mRNA encoding for the GABA-A receptor and BDNF in PMC of schizophrenic patients. | 2015 May |
2 |
| 4 |
25089150 | Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients. | 2014 |
2 |
| 5 |
21179660 | [Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder]. | 2010 |
1 |
| 6 |
17092970 | The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine. | 2007 Aug |
5 |
| 7 |
16522641 | Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. | 2006 May 5 |
2 |